Lower GI 2017

Chinese Study

Inclusion criteria: cT3-4 or N+

T M E

RT 50 Gy (@2.0 Gy) + Capecitabine 1600 mg/m² days 1-14 + 22-25

FOLFOX 6-8 cycles

R

RT 50 Gy (@2.0 Gy) + Capecitabine 1600 mg/m² days 1-14 + 22-25 Oxaliplatin 60 mg/m² d 1, 8 + 22, 29

T M E

FOLFOX 6-8 cycles

Primary endpoint: 3y-OS (84 to 96%); 206 pts